Cellectar Biosciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €42.31M -29.7% -€4.54M -49.4% -10.7% +0.042 pp N/A N/A
    (estimated) €60.20M +8.9% -€8.96M -56.7% -14.9% +0.23 pp N/A N/A
    (estimated) €55.26M +1,605.0% -€20.71M -2.3% -37.5% +6.2 pp N/A N/A
    (estimated) €3.24M +∞% -€21.19M +2.7% -653.7% -6.5 pp N/A N/A
    (estimated) €0.00 +NaN% -€20.62M -45.8% N/A N/A N/A
    €0.00 +NaN% -€38.03M +17.4% N/A -€40.50M +50.7% N/A
    €0.00 +NaN% -€32.40M +32.8% N/A -€26.88M +26.1% N/A
    €0.00 +NaN% -€24.40M +19.3% N/A -€21.32M +11.5% N/A
    €0.00 +NaN% -€20.45M +62.4% N/A -€19.13M +61.7% N/A
    €0.00 +NaN% -€12.59M +6.4% N/A -€11.83M +18.9% N/A
    €0.00 +NaN% -€11.83M +4.8% N/A -€9.95M +5.5% N/A
    €0.00 +NaN% -€11.29M -2.4% N/A -€9.43M +3.6% N/A
    €0.00 +NaN% -€11.57M +119.4% N/A -€9.10M +30.0% N/A
    €0.00 +NaN% -€5.27M +12.5% N/A -€7.00M +0.7% N/A
    €0.00 +NaN% -€4.69M -32.2% N/A -€6.96M -7.4% N/A
    €0.00 +NaN% -€6.91M -24.8% N/A -€7.52M -2.2% N/A
    €0.00 +NaN% -€9.20M +22.6% N/A -€7.68M +38.8% N/A
    €0.00 -100.0% -€7.50M +18.3% N/A -€5.53M +10.9% N/A
    -€9.38K -133.0% -€6.34M -454.8% 67,594.7% +610 pp -€4.99M -25.0% 53,197.1% +770 pp
    €28.43K -65.4% €1.79M -109.4% 6,286.1% +290 pp -€6.66M -26.4% -23,412.4% -120 pp
    €82.15K -23.5% -€19.00M +35.4% -23,125.7% -100 pp -€9.04M -38.7% -11,006.0% +27 pp
    €107.44K +∞% -€14.03M -15.9% -13,060.0% -130 pp -€14.74M +28.6% -13,720.1% -140 pp
    €0.00 +NaN% -€16.68M +136.0% N/A -€11.47M +108.2% N/A
    €0.00 -100.0% -€7.07M +171.4% N/A -€5.51M +172.1% N/A
    €10.73K +153.6% -€2.60M +274.5% -24,264.1% -78 pp -€2.02M +509.8% -18,859.2% -110 pp
    €4.23K -€695.40K -16,430.6% -€331.95K -7,843.1%

    Notifications